FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2808068827> ?p ?o ?g. }

• W2808068827 abstract "Despite the clear endocrine-metabolic relationship between androgenic activity and adiposity, the role of androgens in breast cancer prognosis according to patient’s adiposity is scarcely explored. Here, we aimed at investigating the prognostic value of circulating testosterone in association with patient’s body mass index (BMI). Circulating testosterone and BMI were evaluated at breast cancer diagnosis in 460 estrogen receptor (ER)-positive postmenopausal patients. Local relapse, distant metastasi(e)s and contralateral breast cancer were considered recurrence events. The Kruskal-Wallis test was performed to evaluate if testosterone levels differed within subgroups of categorical tumour characteristics. The Cox proportional hazard regression model was fitted to estimate the impact of standard prognostic factors on relapse-specific hazard ratio (HR). After backward selection, a model including continuous testosterone level, BMI categories (< 25, normal-weight; =25–30, overweight; ≥30 kg/m2, obese), tumour size and lymph nodes number was fitted. Furthermore, Cox models provided the relapse-specific HRs for median, third quartile and 95th percentile compared to the first quartile of testosterone levels, stratified by BMI categories. During a median follow up of 6.3 years, 45 patients relapsed. Testosterone levels significantly increased across BMI categories (p = 0.001). Both circulating testosterone and BMI were positively associated with disease free survival (p = 0.005 and p = 0.021, respectively). A significant interaction was found between testosterone and BMI (p = 0.006). For normal-weight women, testosterone concentration around median (0.403 ng/mL) or third quartile (0.532 ng/mL) showed a high significant HR of relapse (5.52; 95% CI:1.65–18.49 and 4.55; 95% CI:1.09–18.98, respectively). Overweight patients showed increased HR at increasing testosterone levels, reaching a significant high HR (4.68; 95% CI:1.39–15.70) for testosterone values of 0.782 ng/mL (95th percentile). For obese patients HR decreased (not significantly) at increased testosterone concentrations, explaining the interaction between testosterone levels and BMI categories. In ER-positive postmenopausal breast cancer patients, high testosterone levels are associated with worse prognosis in normal-weight and overweight women, whereas in obese seems to be associated with a better outcome. Although the results require further validation, they suggest that assessment of circulating testosterone and BMI could help to identify postmenopausal ER-positive patients at higher risk of relapse and potentially open new therapeutic strategies." @default.
• W2808068827 created "2018-06-21" @default.
• W2808068827 creator A5001627390 @default.
• W2808068827 creator A5004373524 @default.
• W2808068827 creator A5016473783 @default.
• W2808068827 creator A5039753499 @default.
• W2808068827 creator A5040189451 @default.
• W2808068827 creator A5047309150 @default.
• W2808068827 creator A5049635189 @default.
• W2808068827 creator A5049771372 @default.
• W2808068827 creator A5051112332 @default.
• W2808068827 creator A5083102271 @default.
• W2808068827 creator A5088671679 @default.
• W2808068827 creator A5091550659 @default.
• W2808068827 date "2018-06-13" @default.
• W2808068827 modified "2023-10-18" @default.
• W2808068827 title "Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients" @default.
• W2808068827 cites W1511930757 @default.
• W2808068827 cites W1559007275 @default.
• W2808068827 cites W1841022483 @default.
• W2808068827 cites W1967607481 @default.
• W2808068827 cites W1969154275 @default.
• W2808068827 cites W1971293194 @default.
• W2808068827 cites W1979188420 @default.
• W2808068827 cites W1982990106 @default.
• W2808068827 cites W1988411979 @default.
• W2808068827 cites W1991521807 @default.
• W2808068827 cites W2008424689 @default.
• W2808068827 cites W2010080966 @default.
• W2808068827 cites W2014962818 @default.
• W2808068827 cites W2015784383 @default.
• W2808068827 cites W2017864770 @default.
• W2808068827 cites W2025285625 @default.
• W2808068827 cites W2043959415 @default.
• W2808068827 cites W2056790156 @default.
• W2808068827 cites W2061975232 @default.
• W2808068827 cites W2067082722 @default.
• W2808068827 cites W2067096633 @default.
• W2808068827 cites W2073081893 @default.
• W2808068827 cites W2074619468 @default.
• W2808068827 cites W2078714887 @default.
• W2808068827 cites W2082413756 @default.
• W2808068827 cites W2084451319 @default.
• W2808068827 cites W2084669465 @default.
• W2808068827 cites W2085857101 @default.
• W2808068827 cites W2117357260 @default.
• W2808068827 cites W2119237938 @default.
• W2808068827 cites W2121519011 @default.
• W2808068827 cites W2121694426 @default.
• W2808068827 cites W2123415568 @default.
• W2808068827 cites W2127137750 @default.
• W2808068827 cites W2128458647 @default.
• W2808068827 cites W2133100322 @default.
• W2808068827 cites W2140759964 @default.
• W2808068827 cites W2220740939 @default.
• W2808068827 cites W2504906285 @default.
• W2808068827 cites W2740616896 @default.
• W2808068827 cites W4252714226 @default.
• W2808068827 doi "https://doi.org/10.1186/s12885-018-4558-4" @default.
• W2808068827 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6130063" @default.
• W2808068827 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30200915" @default.
• W2808068827 hasPublicationYear "2018" @default.
• W2808068827 type Work @default.
• W2808068827 sameAs 2808068827 @default.
• W2808068827 citedByCount "16" @default.
• W2808068827 countsByYear W28080688272018 @default.
• W2808068827 countsByYear W28080688272019 @default.
• W2808068827 countsByYear W28080688272020 @default.
• W2808068827 countsByYear W28080688272021 @default.
• W2808068827 countsByYear W28080688272022 @default.
• W2808068827 countsByYear W28080688272023 @default.
• W2808068827 crossrefType "journal-article" @default.
• W2808068827 hasAuthorship W2808068827A5001627390 @default.
• W2808068827 hasAuthorship W2808068827A5004373524 @default.
• W2808068827 hasAuthorship W2808068827A5016473783 @default.
• W2808068827 hasAuthorship W2808068827A5039753499 @default.
• W2808068827 hasAuthorship W2808068827A5040189451 @default.
• W2808068827 hasAuthorship W2808068827A5047309150 @default.
• W2808068827 hasAuthorship W2808068827A5049635189 @default.
• W2808068827 hasAuthorship W2808068827A5049771372 @default.
• W2808068827 hasAuthorship W2808068827A5051112332 @default.
• W2808068827 hasAuthorship W2808068827A5083102271 @default.
• W2808068827 hasAuthorship W2808068827A5088671679 @default.
• W2808068827 hasAuthorship W2808068827A5091550659 @default.
• W2808068827 hasBestOaLocation W28080688271 @default.
• W2808068827 hasConcept C121608353 @default.
• W2808068827 hasConcept C126322002 @default.
• W2808068827 hasConcept C134018914 @default.
• W2808068827 hasConcept C143998085 @default.
• W2808068827 hasConcept C207103383 @default.
• W2808068827 hasConcept C2779279991 @default.
• W2808068827 hasConcept C2780221984 @default.
• W2808068827 hasConcept C2780586474 @default.
• W2808068827 hasConcept C44249647 @default.
• W2808068827 hasConcept C50382708 @default.
• W2808068827 hasConcept C530470458 @default.
• W2808068827 hasConcept C68443243 @default.
• W2808068827 hasConcept C71924100 @default.
• W2808068827 hasConceptScore W2808068827C121608353 @default.
• W2808068827 hasConceptScore W2808068827C126322002 @default.

• next